Canaccord analyst Richard Close raised the firm’s price target on LifeStance (LFST) to $10 from $9 and keeps a Buy rating on the shares. The firm said 4Q and 2026 guidance contemplates strong growth to continue with revenue and adj-EBITDA increasing 15% and 24% at the midpoints. The reimbursement rate and utilization environment remains favorable.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LFST: